Medical device company SynerFuse has tapped neurosurgeon Michael Park, MD, PhD, as its chief technology officer. The SynerFuse e-TLIF procedure, an ultralow-energy therapy, is used to address chronic ...

In a prospective cohort study, researchers evaluated the effects of spinal cord stimulation in the treatment of painful diabetic peripheral neuropathy.